Navone N - Search Results

1

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer.

Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, Sahu A, Malik R, Wilder-Romans K, Navone N, Logothetis CJ, Araujo JC, Pisters LL, Tewari AK, Canman CE, Knudsen KE, Kitabayashi N, Rubin MA, Demichelis F, Lawrence TS, Chinnaiyan AM, Feng FY. Prensner JR, et al. Among authors: navone n. Cancer Res. 2014 Mar 15;74(6):1651-60. doi: 10.1158/0008-5472.CAN-13-3159. Epub 2014 Jan 28. Cancer Res. 2014. PMID: 24473064 Free PMC article.

2

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ. Navone NM, et al. J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69. doi: 10.1093/jnci/85.20.1657. J Natl Cancer Inst. 1993. PMID: 7692074

3

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: navone nm. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

4

Prolonged survival with metastatic prostate cancer to bone.

Pisters LL, Troncoso P, Navone N. Pisters LL, et al. Among authors: navone n. J Urol. 1998 Jun;159(6):2100. doi: 10.1016/S0022-5347(01)63271-3. J Urol. 1998. PMID: 9598540 No abstract available.

5

Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.

Ozen M, Navone NM, Multani AS, Troncoso P, Logothetis CJ, Chung LW, von Eschenbach AC, Pathak S. Ozen M, et al. Among authors: navone nm. Cancer Genet Cytogenet. 1998 Oct 15;106(2):105-9. doi: 10.1016/s0165-4608(98)00051-x. Cancer Genet Cytogenet. 1998. PMID: 9797773

6

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500. Clin Cancer Res. 1997. PMID: 9815652

7

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.

Navone NM, Labate ME, Troncoso P, Pisters LL, Conti CJ, von Eschenbach AC, Logothetis CJ. Navone NM, et al. J Urol. 1999 Jan;161(1):304-8. J Urol. 1999. PMID: 10037428

8

Model systems of prostate cancer: uses and limitations.

Navone NM, Logothetis CJ, von Eschenbach AC, Troncoso P. Navone NM, et al. Cancer Metastasis Rev. 1998-1999;17(4):361-71. doi: 10.1023/a:1006165017279. Cancer Metastasis Rev. 1998. PMID: 10453280 Review.

9

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.

Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751

10

Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM. Yang J, et al. Among authors: navone nm. Cancer Res. 2001 Jul 15;61(14):5652-9. Cancer Res. 2001. PMID: 11454720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page